Eek-hoon H. Jho
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
The emerging role of the Hippo signaling pathway in interorgan crosstalk.
Journal: The FEBS journal
Published: January 25, 2026
DKK1 Suppresses Hippo Signaling via PIP3-OGT-LRP6 O-GlcNAcylation in Hepatocellular Carcinoma.
Journal: Cancer communications (London, England)
Published: November 12, 2025
Tankyrase-1-mediated PARsylation directs TFEB partner switching to regulate selective Wnt target gene expression.
Journal: Molecules and cells
Published: September 09, 2025
Syndesmos functions as a tumor suppressor by facilitating epithelial cell adhesion mediated by interactions of E-cadherin and β-catenin.
Journal: Cell death & disease
Published: August 21, 2025
Author Correction: SGK1 inhibition in glia ameliorates pathologies and symptoms in Parkinson disease animal models.
Journal: EMBO molecular medicine
Published: August 11, 2025
Retinoic acid-induced protein 14 links mechanical forces to Hippo signaling.
Journal: EMBO reports
Published: March 18, 2024
Phosphorylation of EIF2S1 (eukaryotic translation initiation factor 2 subunit alpha) is indispensable for nuclear translocation of TFEB and TFE3 during ER stress.
Journal: Autophagy
Published: January 31, 2023
O-GlcNAcylation: An Emerging Protein Modification Regulating the Hippo Pathway.
Journal: Cancers
Published: May 10, 2022
Regulation of Hippo signaling by metabolic pathways in cancer.
Journal: Biochimica et biophysica acta. Molecular cell research
Published: October 06, 2021
Past, present, and future perspectives of transcription factor EB (TFEB): mechanisms of regulation and association with disease.
Journal: Cell death and differentiation
Published: August 12, 2021
Last Updated: 09/26/2026